Award
National Heart, Lung, and Blood Institute 5P01HL158505-04
Metabolomics of cGVHD
Recipient
Dana-Farber Cancer Institute, Boston, MA, United States
Award Amount
$567,033.00
Ceiling
$567,033.00
Awarded
August 29, 2025
Identifier
5P01HL158505-04
This NIH grant supports research to develop new therapies for chronic GVHD by studying metabolic demands in immune and lung cells, using gene editing, RNA sequencing, and drug testing to identify therapeutic targets.
Description
Research grant focused on metabolomics and immunology related to chronic GVHD, aiming to develop new therapies by targeting metabolic pathways in germinal center cells and lung epithelial progenitors using advanced molecular techniques.